New anti-viral drug shows promise for dramatic improvement in hepatitis C treatment

Adding a direct acting anti-viral drug to the standard treatment regimen for hepatitis C significantly increases the cure rate in the most difficult to treat patients, according to a research report published Monday in the online edition of the journal The Lancet.

Read the whole article on Physorg

More from Physorg